(0.10%) 5 251.75 points
(0.04%) 39 656 points
(0.21%) 18 294 points
(-0.09%) $78.19
(0.22%) $2.26
(-0.88%) $2 354.20
(-0.74%) $28.30
(-0.16%) $1 005.60
(0.03%) $0.929
(0.22%) $10.86
(0.00%) $0.798
(-0.29%) $92.40
Quarter results today
(bmo 2024-05-13)
Expected move: +/- 11.80%
@ $19.19
Issued: 13 Feb 2024 @ 11:02
Return: -33.61%
Previous signal: Feb 12 - 15:11
Previous signal:
Return: -0.20 %
Live Chart Being Loaded With Signals
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases...
Stats | |
---|---|
Today's Volume | 351 013 |
Average Volume | 340 677 |
Market Cap | 460.30M |
EPS | $0 ( 2024-03-21 ) |
Next earnings date | ( $0 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.59 |
ATR14 | $0.0260 (0.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-18 | Schoenberg Mark | Sell | 12 000 | Ordinary Shares |
2024-01-31 | Kim Dong | Buy | 3 333 | Ordinary Shares |
2022-03-25 | Kim Dong | Buy | 20 000 | Stock Option (right to buy) |
2024-02-01 | Smith Jason Drew | Sell | 3 328 | Ordinary Shares |
2024-02-01 | Smith Jason Drew | Sell | 1 248 | Ordinary Shares |
INSIDER POWER |
---|
59.16 |
Last 96 transactions |
Buy: 1 308 776 | Sell: 407 960 |
Volume Correlation
Urogen Pharma Ltd Correlation
10 Most Positive Correlations | |
---|---|
SVAC | 0.916 |
GOODM | 0.907 |
TLGT | 0.891 |
MTSL | 0.871 |
NSTS | 0.866 |
TTWO | 0.86 |
LUNG | 0.851 |
PAIC | 0.851 |
WRAP | 0.845 |
RMNI | 0.845 |
10 Most Negative Correlations | |
---|---|
LWAC | -0.955 |
SRAC | -0.919 |
AMRB | -0.902 |
LMRKN | -0.889 |
NETE | -0.881 |
VIRT | -0.853 |
KNSA | -0.847 |
UTHR | -0.847 |
RAVN | -0.84 |
EH | -0.831 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Urogen Pharma Ltd Correlation - Currency/Commodity
Urogen Pharma Ltd Financials
Annual | 2023 |
Revenue: | $82.71M |
Gross Profit: | $73.35M (88.68 %) |
EPS: | $-3.55 |
FY | 2023 |
Revenue: | $82.71M |
Gross Profit: | $73.35M (88.68 %) |
EPS: | $-3.55 |
FY | 2022 |
Revenue: | $64.36M |
Gross Profit: | $56.70M (88.11 %) |
EPS: | $-4.79 |
FY | 2021 |
Revenue: | $48.04M |
Gross Profit: | $42.89M (89.27 %) |
EPS: | $-4.96 |
Financial Reports:
No articles found.
Urogen Pharma Ltd
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-301 for the treatment of high-grade non-muscle invasive bladder cancer. The company has a license agreement with Allergan Pharmaceuticals International Limited for developing and commercializing pharmaceutical products that contain RTGel and clostridial toxins; Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for high-grade bladder cancer. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators